| 马骁 蕫庆 刘恋 张凯 赵桂彬 崔键△.肺癌数字化临床路径管理平台的构建和初步应用[J].现代生物医学进展英文版,2016,16(25):4859-4863. |
| 肺癌数字化临床路径管理平台的构建和初步应用 |
| Construction and Application of Digital Clinical Pathway ManagementPlatform in Lung Cancer |
| |
| DOI： |
| 中文关键词: 肺癌 数字化临床路径 数字化临床路径管理平台 住院天数 住院费用 |
| 英文关键词: Lung Cancer Digital Clinical Pathway Digital Clinical Pathway Management Platform Hospitalization days Hospitalization
expenses |
| 基金项目:黑龙江省应用技术研究与开发计划项目（GA14C101-08） |
|
| Hits: 830 |
| Download times: 0 |
| 中文摘要: |
| 目的：构建肺癌数字化临床路径并研究其在临床中应用优势。方法：收集2013 年8 月- 2016 月3 月于哈医大四院胸外二科
入院的肺癌手术患者，150 名患者通过肺癌数字化临床路径管理系诊治（临床路径组），150 人通过常规方式诊疗（对照组），比较
两组最终的住院天数和住院总费用。结果：临床路径组的住院总天数、住院总费用均小于对照组（P< 0.05 或0.01）。结论：数字化
肺癌路径管理平台在临床病人管理中具有一定的优势。 |
| 英文摘要: |
| Objective:To build digital clinical pathway of lung cancer and study its advantage in clinical application.Methods:150 patients with lung cancer surgery were treated by digital clinical pathway management (clinical pathway group), the other 150 patients
with lung cancer surgery were treated by the usual way of diagnosis and treatment (the control group) from August 2013 to March
2016 in thoracic department of the Fourth Affiliated Hospital of Harbin Medical University. Compare of the two group with lung cancer
surgery eventually in hospitalization days and total hospitalization expenses.Results:By comparing the results, both the clinical pathway
group total hospitalization days and total hospitalization costs are less than the control group, the test P < 0.05 or 0.01, are statistically significant.Conclusion:Digital clinical pathway management platform of lung cancer in the management of patients has a certain advantage. |
|
View Full Text
View/Add Comment Download reader |
| Close |
